About
Glucose-responsive Insulin
Areas of Focus
Categories
Biologics & BiopharmaceuticalSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
176
By Phase
NA: 3
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07090395Lead Sponsor
Severe Label Expansion for EVO Products Trial
NARecruiting
49 participants
Started: Aug 1, 2025 · Completed: Dec 31, 2026
NCT06956794Collaborator
Multimodal Training With Immersive Virtual Reality to Improve the Cognitive Health and Emotional Well-being of Older Women Living Alone
NAActive, not recruiting
80 participants
Started: May 5, 2025 · Completed: Jun 1, 2026
NCT06267976Lead Sponsor
Validation of the ProSomnus® RPMO2 Device
N/ACompleted
12 participants
Started: Jun 10, 2024 · Completed: Jun 30, 2025
NCT05445869Lead Sponsor
Severe OSA Study (SOS)
NATerminated
35 participants
Started: Sep 12, 2022 · Completed: Feb 15, 2024
Locations (1)
Headquarters
Pasadena, CA, United States
Map
Loading map...